Beatrice Rangone

Beatrice Rangone

Auto-generated profile, based on publicly available information

Beatrice Rangone

Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, 15121 Alessandria, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Maurizio SabbatiniMaurizio Sabbatini
Maurizio Sabbatini
IZIlaria Zanellato
Ilaria Zanellato
Mauro RaveraMauro Ravera
Mauro Ravera
Elisabetta GabanoElisabetta Gabano
Elisabetta Gabano
EPElena Perin
Elena Perin
Domenico OsellaDomenico Osella
Domenico Osella

22 September 2017 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Elisabetta GabanoElisabetta Gabano
Elisabetta Gabano
Mauro RaveraMauro Ravera
Mauro Ravera
IZIlaria Zanellato
Ilaria Zanellato
STStefano Tinello
Stefano Tinello
AGAndrea Gallina
Andrea Gallina
Domenico OsellaDomenico Osella
Domenico Osella
The design, synthesis, characterization and biological properties of a Pt(IV) complex containing the very active inhibitor of histone deacetylase (2-propynyl)octanoic acid, POA, as an axial ligand are reported here. The title complex, namely (OC-6-44)-acetatodiamminedichlorido(2-(2-propynyl)octanoato)platinum(IV), 1, containing POA in racemic or in enantiomeric forms, was one/two orders of magnitude more active than cisplatin, depending on the chemo-sensitivity of the cancer cell lines. Moreover, 1 exhibited similar or even better antiproliferative activity than (OC-6-33)-diamminedichloridobis(2-propylpentanoato)platinum(IV), 2, containing two molecules of the well-known histone deacetylase inhibitor 2-propylpentanoic (valproic) acid. The high potency of 1 is likely due to its high cellular accumulation and to the synergism between the DNA-damaging cisplatin and the histone deacetylase inhibitor POA, both released upon the intracellular reduction of 1. Prodrug 1, after oral administration, caused an impressive reduction of the tumor mass (94%) in a model of solid tumor (murine Lewis lung carcinoma), compared to that of the control, whereas (intraperitoneal) cisplatin induced a tumor regression of 75% only. A good accumulation of 1 was observed in the tumor mass. The time course of the body weight attested that cisplatin induced elevated anorexia, whereas treatment with 1 did not induce significant body weight loss throughout the therapeutic experiment.

6 December 2018 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Elisabetta GabanoElisabetta Gabano
Elisabetta Gabano
Mauro RaveraMauro Ravera
Mauro Ravera
EPElena Perin
Elena Perin
IZIlaria Zanellato
Ilaria Zanellato
BRB. Rangone
B. Rangone
Domenico OsellaDomenico Osella
Domenico Osella
Three pairs of asymmetric dicarboxylato derivatives based on the cisplatin and oxaliplatin-like skeletons have been synthesized de novo or re-synthesized. The axial ligands consist of one medium-chain fatty acid (MCFA), namely clofibrate (i.e. 2-(p-chlorophenoxy)-2-methylpropionic acid, CA), heptanoate (HA) or octanoate (OA), respectively, and an inactive acetato ligand that imparts acceptable water solubility to such conjugates. Stability tests provided evidence for the partial formation of two hydrolyzed products, corresponding to two monoaqua diastereomers derived from the substitution of an equatorial chlorido ligand with a water molecule. The complexes have been tested on three different colon cancer cell lines having different histological history, and also on the cisplatin-sensitive A2780 ovarian cancer cell line for comparison. This allowed the evaluation not only of the increase in activity on passing from Pt(II) to Pt(IV) derivatives, but also the selectivity towards colon cancer cells brought about by the cyclohexane-1R,2R-diamine carrier ligand.

12 July 2017 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Elisabetta GabanoElisabetta Gabano
Elisabetta Gabano
EPElena Perin
Elena Perin
CFC. Fielden
C. Fielden
James PlattsJames Platts
James Platts
AGA. Gallina
A. Gallina
Mauro RaveraMauro Ravera
Mauro Ravera
Oxidation of [Pt(II)Cl(terpy)]+ (terpy = 2,2′:6′,2′′-terpyridine) has been attempted with several oxidizing agents and under different experimental conditions in order to obtain a Pt(IV) complex suitable for the conjugation to nanovectors to be used in drug delivery targeting for anticancer therapy. The best compromise in terms of yield and purity of the final complex was obtained by microwave-assisted reaction at 70 °C in 50% aqueous H2O2 for 2 h. Under these conditions the quantitative formation of [Pt(IV)Cl(OH)2(terpy)]+ was observed. The subsequent synthetic steps were, (i) functionalization of [Pt(IV)Cl(OH)2(terpy)]+ in the axial position with succinic anhydride to obtain [Pt(IV)Cl(OH)(succinato)(terpy)]+ and (ii) reaction of the latter with nonporous silica nanoparticles (SNPs) with an external shell containing primary amino groups to obtain a nanovector able to transport the Pt(IV) antitumor prodrug in the form of a conjugate Pt-SNP. Finally, the antiproliferative activity and cell accumulation of [Pt(II)Cl(terpy)]+, [Pt(IV)Cl(OH)2(terpy)]+, and the Pt-SNP conjugate were measured on three cancer cell lines. Despite highly effective accumulation of Pt-SNP in cells, a modest increase in activity was observed with respect to the molecular species. Further experiments showed that the Pt-SNP conjugate can release [Pt(II)Cl(terpy)]+ upon reduction, but this metabolite may undergo hydrolysis, and the resulting aquo complex could coordinate once again the free amino groups of the SNPs. In the resulting tetraamine form, the Pt(II) complex conjugated to the SNPs cannot completely perform its antiproliferative activity.

19 June 2021 in Bioinorganic Chemistry and Applications
Verified
Journal Article
Open access
PDF file
Mauro RaveraMauro Ravera
Mauro Ravera
Elisabetta GabanoElisabetta Gabano
Elisabetta Gabano
EPElena Perin
Elena Perin
BRBeatrice Rangone
Beatrice Rangone
DBDiego Bonzani
Diego Bonzani
Domenico OsellaDomenico Osella
Domenico Osella
The possibility of spontaneous self-assembly of dicarboxylato Pt(IV) prodrugs and the consequences on their uptake in cancer cells have been evaluated in different aqueous solutions. Four Pt(IV) complexes, namely, (OC-6-33)-diacetatodiamminedichloridoplatinum(IV), Ace, (OC-6-33)-diamminedibutanoatodichloridoplatinum(IV), But, (OC-6-33)-diamminedichloridodihexanoatoplatinum(IV), Hex, and (OC-6-33)-diamminedichloridodioctanoatoplatinum(IV), Oct, have been dispersed in i) milliQ water, ii) phosphate buffered saline, and iii) complete cell culture media (RPMI 1640 or DMEM) containing fetal bovine serum (FBS). The samples have been analyzed by dynamic light scattering (DLS) to measure the size and distribution of the nanoparticles possibly present. The zeta potential offered an indication of the stability of the resulting aggregates. In the case of the most lipophilic compounds of the series, namely, Oct and to a lesser extent Hex, the formation of nanosized aggregates has been observed, in particular at the highest concentration tested (10μM). The cell culture media had the effect to disaggregate these nanoparticles, mainly by virtue of their albumin content, able to interact with the organic chains via noncovalent (hydrophobic) interactions. For Oct, at the highest concentration employed for the uptake tests (10μM), the combination between passive diffusion and endocytosis of the self-assembled nanoparticles makes the cellular uptake higher than in the presence of passive diffusion only. During the study of cellular uptake on A2780 ovarian cancer cells pretreated with cytochalasin D, a statistically significant inhibition of endocytosis was observed for Oct. In these experimental conditions, the relationship between uptake and lipophilicity becomes almost linear instead of exponential. Since Oct anticancer prodrug is active at nanomolar concentrations, where the aggregation in culture media is almost abolished, this phenomenon should not significantly impact its antiproliferative activity.